Effects of Proxelan Somministration in Patients With Chronic Prostatitis

U

University of Pisa

Status and phase

Unknown
Phase 3

Conditions

Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Chronic Prostatitis
Premature Ejaculation

Treatments

Drug: Proxelan

Study type

Interventional

Funder types

Other

Identifiers

NCT03629769
1103 / 2016

Details and patient eligibility

About

The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

Enrollment

30 estimated patients

Sex

Male

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- prostatitis like symptoms for at least three months

Exclusion criteria

  • significant post-voidal residual volume
  • Meares and Stamey test suggestive for bacterial infection
  • neoplasms,
  • urinary stones,
  • antibiotic therapy in the previous three months,
  • irritable bowel syndrome,
  • previous radiotherapic or chemiotherapic treatment,
  • urethral stenosis,
  • neurogenic bladder
  • previous prostatic surgery

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patients with prostatitis-like symptoms
Experimental group
Description:
Cohort of patients with CP/CPPS (abacterial prostatitis)
Treatment:
Drug: Proxelan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems